Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17527093 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir;   Drug: lamivudine/zidovudine;   Drug: efavirenz;   Drug: lamivudine;   Drug: stavudine;   Drug: zidovudine;   Drug: didanosine

Indicates status has not been verified in more than two years